Lize Kiakouama-Maleka

Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting

Pauline Corbaux, Denis Maillet, Amélie Boespflug et al. · European Journal of Cancer · 2019 · 83 citations · Full text

Life Sciences, Immunology, Oncology +14

Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

Denis Maillet, Pauline Corbaux, Jean‐Jacques Stelmes et al. · European Journal of Cancer · 2020 · 76 citations

Life Sciences, Immunology, Oncology +16

A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity

Judith Provoost, Florent Valour, D. Gamondès et al. · BMC Infectious Diseases · 2018 · 21 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes

Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle et al. · Cancers · 2021 · 21 citations · Full text

Life Sciences, Immunology, Oncology +15

First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial

A. Lavolé, Laurent Greillier, Julien Mazières et al. · European Respiratory Journal · 2020 · 14 citations · Full text

Medicine, Oncology, Chemotherapy +11